J. Pelletier, J. Martel-pelletier, and D. Howell, Etiopathogenesis of osteoarthritis Arthritis & allied conditions: a textbook of rheumatology, pp.2195-245, 2000.

J. Pelletier, J. Martel-pelletier, and S. Abramson, Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targets, Arthritis & Rheumatism, vol.379, issue.6, pp.1237-1284, 2001.
DOI : 10.1097/00003086-200010001-00036

J. Martel-pelletier, D. Battista, J. Lajeunesse, and D. , Biochemical Factors in Joint Articular Tissue Degradation in Osteoarthritis, Osteoarthritis: clinical and experimental aspects, pp.156-87, 1999.
DOI : 10.1007/978-3-642-60026-5_9

A. Amin, M. Attur, R. Patel, G. Thakker, P. Marshall et al., Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide., Journal of Clinical Investigation, vol.99, issue.6, pp.1231-1238, 1997.
DOI : 10.1172/JCI119280

K. Notoya, D. Jovanovic, P. Reboul, J. Martel-pelletier, F. Mineau et al., The Induction of Cell Death in Human Osteoarthritis Chondrocytes by Nitric Oxide Is Related to the Production of Prostaglandin E2 Via the Induction of Cyclooxygenase-2, The Journal of Immunology, vol.165, issue.6, pp.3402-3412, 2000.
DOI : 10.4049/jimmunol.165.6.3402

F. Blanco, R. Guitian, E. Vázquez-martul, F. De-toro, and F. Galdo, Osteoarthritis chondrocytes die by apoptosis: A possible pathway for osteoarthritis pathology, Arthritis & Rheumatism, vol.74, issue.2, pp.284-293, 1998.
DOI : 10.1002/aja.1002030409

URL : http://onlinelibrary.wiley.com/doi/10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T/pdf

J. Musser and A. Kreft, 5-Lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors, Journal of Medicinal Chemistry, vol.35, issue.14, pp.2501-2525, 1992.
DOI : 10.1021/jm00092a001

E. Hansen, K. Fogh, V. Hjortdal, T. Henriksen, I. Noer et al., : Carragheenan-induced gonarthritis studied in dogs, Acta Orthopaedica Scandinavica, vol.15, issue.1, pp.207-219, 1990.
DOI : 10.1007/BF01964718

URL : http://www.tandfonline.com/doi/pdf/10.3109/17453679008993502?needAccess=true

O. Atik, Leukotriene B4 and prostaglandin E2-like activity in synovial fluid in osteoarthritis, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.39, issue.4, pp.253-257, 1990.
DOI : 10.1016/0952-3278(90)90002-3

P. Bertin, F. Lapicque, E. Payan, M. Rigaud, F. Bailleul et al., Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid, European Journal of Clinical Pharmacology, vol.46, issue.1, pp.3-7, 1994.
DOI : 10.1007/BF00195907

K. Rainsford, C. Ying, and F. Smith, Effects of 5???Lipoxygenase Inhibitors on Interleukin Production by Human Synovial Tissues in Organ Culture: Comparison with Interleukin???1???synthesis Inhibitors*, Journal of Pharmacy and Pharmacology, vol.85, issue.Suppl. 4, pp.46-52, 1996.
DOI : 10.1073/pnas.85.18.6802

M. Amat, C. Diaz, and L. Vila, Leukotriene A4 hydrolase and leukotriene C4 synthase activities in human chondrocytes: Transcellular biosynthesis of leukotrienes during granulocyte-chondrocyte interaction, Arthritis & Rheumatism, vol.49, issue.9, pp.1645-51, 1998.
DOI : 10.1002/1529-0131(199809)41:9<1645::AID-ART16>3.0.CO;2-Z

S. Laufer, S. Tries, A. J. Dannhardt, and G. , Pharmacological profile of a new pyrrolizine derivative inhibiting the enzymes cyclo-oxygenase and 5-lipoxygenase, Arzneimittelforschung, vol.44, pp.629-665, 1994.

S. Laufer, Discovery and development of ML 3000, Inflammopharmacology . In press

S. Laufer, S. Tries, A. J. Elsasser, R. Albrecht, W. Guserle et al., Acute and chronic anti-inflammatory properties of [2,2- dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine- 5-yl]-acetic acid, Arzneimittelforschung, vol.45, pp.27-32, 1995.

S. Laufer, S. Tries, A. J. Elsasser, R. Algate, D. Atterson et al., Gastrointestinal tolerance of [2,2-dimethyl-6-(4-chlorophe- nyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid in the rat, Arzneimittelforschung, vol.44, pp.1329-1362, 1994.

J. Wallace, L. Carter, W. Mcknight, S. Tries, and S. Laufer, ML 3000 reduces gastric prostaglandin synthesis without causing mucosal injury, European Journal of Pharmacology, vol.271, issue.2-3, pp.525-556, 1994.
DOI : 10.1016/0014-2999(94)90814-1

K. Rainsford, Inhibition by Leukotriene Inhibitors, and Calcium and Platelet-activating Factor Antagonists, of Acute Gastric and Intestinal Damage in Arthritic Rats and in Cholinomimetic-treated Mice, Journal of Pharmacy and Pharmacology, vol.248, issue.Suppl.725, pp.331-340, 1999.
DOI : 10.1016/0014-2999(85)90582-5

M. Adams and J. Pelletier, Canine anterior cruciate ligament transection model of osteoarthritis, Animal models for the rheumatic diseases, pp.57-81, 1990.

K. Brandt, Insights into the Natural History of Osteoarthritis Provided by the Cruciate-Deficient Dog., Annals of the New York Academy of Sciences, vol.32, issue.1 Inhibition of, pp.199-205, 1994.
DOI : 10.1016/0021-9290(84)90075-7

J. Fernandes, J. Martel-pelletier, I. Otterness, A. Lopez-anaya, F. Mineau et al., Effects of tenidap on canine experimental osteoarthritis i. morphologic and metalloprotease analysis, Arthritis & Rheumatism, vol.19, issue.9, pp.1290-303, 1995.
DOI : 10.1042/bj2480265

J. Pelletier, F. Mineau, J. Raynauld, J. Woessner, . Jr et al., Intraarticular Injections with Methylprednisolone Acetate Reduce Osteoarthritic Lesions in Parallel with Chondrocyte Stromelysin Synthesis in Experimental Osteoarthritis, Arthritis & Rheumatism, vol.27, issue.3, pp.414-437, 1994.
DOI : 10.1002/art.1780370316

J. Pelletier, V. Lascau-coman, D. Jovanovic, J. Fernandes, P. Manning et al., Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors, J Rheumatol, vol.26, pp.2002-2016, 1999.

J. Fernandes, J. Martel-pelletier, D. Jovanovic, G. Tardif, D. Battista et al., The effects of tenidap on canine experimental osteoarthritis. II. Study of the expression of collagenase-1 and interleukin-1beta by in situ hybridization, J Rheumatol, vol.25, pp.951-959, 1998.

J. Pelletier, D. Lajeunesse, D. Jovanovic, V. Lascau-coman, F. Jolicoeur et al., Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis, J Rheumatol, vol.27, pp.2893-902, 2000.

J. Pelletier and J. Martel-pelletier, In vivo protective effects of prophylactic treatment with tiaprofenic acid or intraarticular corticosteroids on osteoarthritic lesions in the experimental dog model, J Rheumatol, vol.27, pp.127-157, 1991.

D. Howell, R. Altman, J. Pelletier, J. Martel-pelletier, and D. Dean, Disease modifying anti-rheumatic drugs: current status of their application in animal models of osteoarthritis, Osteoarthritis disorders. Rosemont (IL), pp.365-78, 1995.

D. Howell, O. Muniz, D. Dean, R. Altman, J. Pelletier et al., Concepts of chondroprotective agents and use of animal models to test them A brief review of cartilage changes in osteoarthritis, pp.142-146, 1990.

D. Howell, M. Carreno, J. Pelletier, and O. Muniz, Articular Cartilage Breakdown in a Lapine Model of Osteoarthritis, Clinical Orthopaedics and Related Research, vol.&NA;, issue.213, pp.69-76, 1986.
DOI : 10.1097/00003086-198612000-00009

L. Yu, . Jr, G. Smith, . Jr, K. Brandt et al., Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline, Arthritis & Rheumatism, vol.32, issue.10, pp.1150-1159, 1992.
DOI : 10.1042/bst0180812

M. Palmoski and K. Brandt, In vivo effect of aspirin on canine osteoarthritic cartilage, Arthritis & Rheumatism, vol.36, issue.8, pp.994-1001, 1983.
DOI : 10.1042/bj0570301

H. Mankin, H. Dorfman, L. Lippiello, and A. Zarins, Biochemical and Metabolic Abnormalities in Articular Cartilage from Osteo-Arthritic Human Hips, The Journal of Bone & Joint Surgery, vol.53, issue.3, pp.523-560, 1971.
DOI : 10.2106/00004623-197153030-00009

J. Pelletier, J. Martel-pelletier, L. Ghandur-mnaymneh, D. Howell, J. Woessner et al., Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis, Arthritis & Rheumatism, vol.28, issue.5, pp.554-61, 1985.
DOI : 10.1042/bj1800095

F. Moldovan, J. Pelletier, J. Hambor, J. Cloutier, and J. Martel-pelletier, Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ. In vitro mimicking effect by transforming growth factor ??, Arthritis & Rheumatism, vol.8, issue.9, pp.1653-61, 1997.
DOI : 10.1016/S0934-8832(11)80068-5

E. Husni, L. Simon, G. Tsokos, L. Moreland, G. Kammer et al., NSAID therapy: current concepts, Modern therapeutics in rheumatic diseases. Totowa (NJ)

E. Huskisson, H. Berry, P. Gishen, R. Jubb, J. Whitehead et al., Longitudinal Investigation of Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis) Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee, J Rheumatol, vol.22, pp.1941-1947, 1995.

J. Pelletier, D. Battista, J. Raynauld, J. Wilhelm, S. Martel-pelletier et al., The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1 and oncogene protein synthesis in experimental osteoarthritis, Lab Invest, vol.72, pp.578-86, 1995.

J. Fernandes, J. Caron, J. Martel-pelletier, D. Jovanovic, F. Mineau et al., Effects of tenidap on the progression of osteoarthritic lesions in a canine experimental model. Suppression of metalloprotease and interleukin-1 activity, Arthritis & Rheumatism, vol.22, issue.2, pp.284-94, 1997.
DOI : 10.1042/bj2480265

J. Sipe, L. Bartle, and L. Loose, Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen: a possible correlate with clinical acute phase response, J Immunol, vol.148, pp.480-484, 1992.

J. Caron, J. Fernandes, J. Martel-pelletier, G. Tardif, F. Mineau et al., Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression, Arthritis & Rheumatism, vol.38, issue.9, pp.1535-1579, 1996.
DOI : 10.1016/0925-4439(94)90028-0

S. Laufer, A. J. Dannhardt, G. Kiefer, and W. , 7-diaryldihy- dropyrrolizin-5-yl) acetic acids, a novel class of potent dual inhibitors of both cyclooxygenase and 5-lipoxygenase, J Med Chem, vol.637, pp.1894-1901, 1994.

T. Carty, F. Sweeney, R. Griffiths, J. Eskra, M. Ernest et al., Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models, Inflammation Research, vol.46, issue.5, pp.168-79, 1997.
DOI : 10.1007/s000110050163

P. Prete and A. Gurakar-osborne, The Contribution of Synovial Fluid Lipoproteins to the Chronic Synovitis of Rheumatoid Arthritis, Prostaglandins, vol.54, issue.4, pp.689-98, 1997.
DOI : 10.1016/S0090-6980(97)00147-0

T. Herlin, K. Fogh, H. Ewald, E. Hansen, V. Knudsen et al., Changes in lipoxygenase products from synovial fluid in carragheenan induced arthritis in dogs, APMIS, vol.255, issue.Suppl. 222, pp.601-605, 1988.
DOI : 10.1111/j.1476-5381.1985.tb11082.x

J. Pelletier and J. Martel-pelletier, Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the pond-nuki dog model of osteoarthritis, Arthritis & Rheumatism, vol.58, issue.2, pp.181-93, 1989.
DOI : 10.1042/cs0610703

J. Martel-pelletier and J. Pelletier, WANTED???THE COLLAGENASE RESPONSIBLE FOR THE DESTRUCTION OF THE COLLAGEN NETWORK IN HUMAN CARTILAGE!, Rheumatology, vol.35, issue.9, pp.818-838, 1996.
DOI : 10.1093/rheumatology/35.9.818